Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus.

Journal of cancer research and clinical oncology - 2 Feb 2024

Xu Fanhuan, Jin Jiacheng, Guo Juan, Xu Feng, Chen Jianan, Liu Qi, Song Luxi, Zhang Zheng, Zhou Liyu, Su Jiying, Xiao Chao, Zhang Yumei, Yan Meng, He Qi, Wu Dong, Chang Chunkang, Li Xiao, Wu Lingyun

Abstract excerpt

PURPOSE: Diabetes mellitus (DM) is the second most common comorbidity in myelodysplastic syndromes (MDS). The purpose of the study was to investigate the clinical characteristics of MDS patients with DM. METHODS: A retrospective analysis was performed on the clinical data of 890 MDS patients with or without DM. Clinical data, including genetic changes, overall survival (OS), leukemia-free survival (LFS) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus
Share to Leukemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Prognosis

Share to Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 38305890
DOI: 10.1007/s00432-023-05591-4
PMCID: PMC10837231

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus.PMID 38305890Read ↗

The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitusSemantic proximity Read ↗

Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia-A population-based study.Semantic proximity Read ↗

Hyperglycemia cooperates with Tet2 heterozygosity to induce leukemia driven by proinflammatory cytokine–induced lncRNA MorrbidSemantic proximity Read ↗

Mutation of ten-eleven translocation-2 is associated with increased risk of autoimmune disease in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Diabetes as a risk factor for medication-related osteonecrosis of the jaw.Semantic proximity Read ↗

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia.Semantic proximity Read ↗

Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Post-transplant complications revealed by mycophenolate mofetil related transporters and metabolic enzymes gene polymorphisms in pediatric patients with hematological disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.